Patients with inflammatory bowel disease (IBD) are 70% more likely to use benzodiazepines and “Z-drugs” than are the general population, a large study from Canada suggests. Mood/anxiety disorders and sleep disorders are common in patients with IBD, but few studies have looked at use of benzodiazepine and Z-drugs (such as zolpidem, zaleplon, and eszopiclone) in … Read more
Patients with schizophrenia are at increased risk of developing inflammatory bowel disease (IBD) compared with the general population, according to a large study from Taiwan that provides more evidence of a gut-brain link. The study also shows that patients with schizophrenia develop IBD at a younger age and that the risk increases with inadequately controlled … Read more
People with eosinophilic esophagitis (EoE) may run an increased risk of mood disorders, anxiety, and attention-deficit/hyperactivity disorder (ADHD) and should be screened for those conditions, researchers say. “It’s important to know that there is an elevated risk of those diagnoses, so you have that in mind when you treat your patients. You can assess their … Read more
Anxiety and depression are common among individuals with inflammatory bowel disease (IBD) who are in remission, and the conditions are linked to unemployment and presenteeism, according to a prospective study. Previous studies have found a heightened risk of anxiety and depression in IBD, as well as an association with poor treatment compliance and greater morbidity. … Read more